Warning!
This copy of Website Builder is licensed for another domain!

Was it working good before? If you just parked additional domain to this website,
maybe this is a problem - please go to website builder again and update your license with new domain
- or contact your website builder provider

About » CHANDA LLC. - Beyond Cosmetics

About






Chanda Zaveri



  Chanda Zaveri, M.S.

As founder and president, Ms. Zaveri is the driving force behind all developments at Activor. A molecular biologist, geneticist, and protégé to two time Nobel Laureate Dr. Linus Pauling, Ms. Chanda Zaveri is a driving force behind the evolution of the biotechnology industry. Her most recent contributions include innovative developments in cosmeceuticals, nutriceuticals, wound-healing technology and cancer chemotherapeutics.


Ms. Zaveri received a Masters degree in Molecular Biology and Genetics from the University of California at Santa Barbara. Subsequent graduate studies were undertaken at California Institute of Technology (Caltech). After working with a major phamaceutical corporation in Southern California, Ms. Zaveri chose to pursue her own scientific visions as an entrepreneur. Her subsequent accomplishments have proven her steadfast commitment to scientific integrity and global vision for the application of her research findings. The respect enjoyed by Ms. Zaveri among her scientific and medical colleagues rightly confirms her status as an innovative and leading personality in the expanding world of biotechnology. Ms. Zaveri holds several patents, and has been offered many awards, most notably an honorary doctorate for her discoveries in skin pigment formation. For more than seven years, she has worked diligently to unite her research findings with marketable applications in cosmetics and nutriceuticals. Ms. Zaveri’s ongoing goal is to build a company that specializes in peptide chemistry and pharmaceutical innovations

 

Ms. Zaveri’s initial investigation into dermaceuticals started in 1993 with the creation of a biologically active peptide that stimulated collagen synthesis. This technology served as the sole intellectual property asset of Ms. Zaveri’s initial corporate endeavor, which began in 1994.   After moving onwards in 1998 to create the Activor Corporation, Ms. Zaveri continued her work in dermaceuticals and shifted her focus toward the evolving science of biologically active wound healing products.